Galectin 3 expression in primary oral squamous cell carcinomas.

about

Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas

P2860

Q58774110-8DF8108A-EBA2-4FAD-811E-7929C0E6FC55

P2860

Galectin 3 expression in primary oral squamous cell carcinomas.

Item

http://www.wikidata.org/entity/Q47249097

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Galectin 3 expression in primary oral squamous cell carcinomas.

@en

Galectin 3 expression in primary oral squamous cell carcinomas.

@nl

type

Item

label

Galectin 3 expression in primary oral squamous cell carcinomas.

@en

Galectin 3 expression in primary oral squamous cell carcinomas.

@nl

prefLabel

Galectin 3 expression in primary oral squamous cell carcinomas.

@en

Galectin 3 expression in primary oral squamous cell carcinomas.

@nl

P1476

Galectin 3 expression in primary oral squamous cell carcinomas

@en

P2093

Carol I Geppert

http://www.w3.org/2001/XMLSchema#string

Falk Wehrhan

http://www.w3.org/2001/XMLSchema#string

Friedrich W Neukam

http://www.w3.org/2001/XMLSchema#string

Jutta Ries

http://www.w3.org/2001/XMLSchema#string

Maike Büttner-Herold

http://www.w3.org/2001/XMLSchema#string

Patrick Moebius

http://www.w3.org/2001/XMLSchema#string

Raimund Preidl

http://www.w3.org/2001/XMLSchema#string

P2860

Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse

Galectin-3--a jack-of-all-trades in cancer.

Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences

Increased malignancy of oral squamous cell carcinomas (oscc) is associated with macrophage polarization in regional lymph nodes - an immunohistochemical study

Galectin-3: an open-ended story.

Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma.

Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells.

Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical Cancer

Macrophage polarisation changes within the time between diagnostic biopsy and tumour resection in oral squamous cell carcinomas--an immunohistochemical study.

Regulatory roles of galectins in the immune response.

P2888

s12885-017-3920-2

P304

906

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-017-3920-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Luitpold Distel

Manuel Weber

P577

2017-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100104625

http://www.w3.org/2001/XMLSchema#string

P698

29284429

http://www.w3.org/2001/XMLSchema#string

P932

5747141

http://www.w3.org/2001/XMLSchema#string

Galectin 3 expression in primary oral squamous cell carcinomas.

about

P2860

P2860

Galectin 3 expression in primary oral squamous cell carcinomas.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932